How our psoriatic arthritis trial helped Andrew
Patients from the TICOPA trial, which tested the effectiveness of very tight and responsive management of symptoms of psoriatic arthritis, are already seeing the benefits. Andrew Parkinson, from Otley, was one of over 200 patients who took part.
Andrew developed psoriatic arthritis at the age of 50, when he first noticed it in his hands and he started waking up in the middle of the night with cramp.
His GP told him to give up golf. He had lots of tests but wasn't tested for arthritis. By the time he was finally referred to a rheumatologist, the arthritis had gone into his ankles, knees and elbows. He had difficulty walking a few hundred yards and he says the pain was “unbelievable.”
When Andrew was diagnosed with psoriatic arthritis, he was told about the TICOPA trial. He went onto methotrexate and sulfasalazine, then quickly onto etanercept, which he's still on. He's done extremely well, has had no side-effects and the damage has greatly reduced in his hands. He puts this down partly to getting on TICOPA so quickly.
He's now a patient rep for TICOPA and is on the steering committee of RETREAT, Philip Helliwell’s pilot study testing withdrawing drugs in psoriatic patients who are stable on therapy.